The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dr Martens PLC
LSE:DOCS
|
UK |
|
K
|
Kistron Co Ltd(Gyeonggi-do)
KOSDAQ:475430
|
KR |
|
G
|
Good Finance Securities Co Ltd
TPEX:6021
|
TW |
|
F
|
First Paramount Modaraba
KAR:FPRM
|
PK |
|
X
|
Xu Yuan Packaging Technology Co Ltd
TPEX:8421
|
TW |
|
H
|
Homeco Victoria Makmur PT Tbk
IDX:LIVE
|
ID |
|
B
|
Bloomios Inc
OTC:BLMS
|
US |
|
M
|
Mars Semiconductor Corp
TPEX:6708
|
TW |
|
J
|
Janana De Malucho Textile Mills Ltd
KAR:JDMT
|
PK |
|
Raba Jarmuipari Holding Nyrt
F:RMV1
|
HU |
|
S
|
Shen's Art Printing Co Ltd
TPEX:8921
|
TW |
|
A
|
At-Tahur Ltd
KAR:PREMA
|
PK |
|
Lithium Chile Inc
F:KC3
|
CA |
|
V
|
Vereinigte Filzfabriken AG
XMUN:VFF
|
DE |
|
Hermes International SCA
F:HMI
|
FR |
|
B
|
Berkshire Hathaway Inc
F:BRH
|
US |
|
I
|
IDeA Indonesia Akademi Tbk PT
IDX:IDEA
|
ID |
|
I
|
Ibrahim Fibres Ltd
KAR:IBFL
|
PK |
|
F
|
First Capital Equities Limted
KAR:FCEL
|
PK |
|
Dr Martens PLC
F:3U2
|
UK |
|
B
|
Bhanero Textile Mills Ltd
KAR:BHAT
|
PK |
|
W
|
Wah Nobel Chemicals Ltd
KAR:WAHN
|
PK |
|
Sberbank Rossii PAO
MOEX:SBER
|
RU |
|
Royal Prima Tbk PT
IDX:PRIM
|
ID |
Dr Martens PLC (DOCS)’s 12-month stock price forecast through October 2027 has a consensus target of 96.9 GBX, implying 46% upside. The forecast is based on price targets from 6 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
DOCS is 96.9 GBX with a low forecast of 70.7 GBX and a high forecast of 115.5 GBX.
Over the last 7 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 7 years is 5%.
Over the last 7 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 4 years is 4%.
Over the last 7 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 7 years is 10%.
Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 2%. The projected CAGR for the next 3 years is 43%.
Over the last 7 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 3 years is 42%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more